News25/Ratings0
News · 26 weeks54+13%
2026-03-012026-08-23
Mix2690d
- SEC Filings16(62%)
- Other9(35%)
- Insider1(4%)
Latest news
25 items- PRCDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide MarketNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 25, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has entered into a SAFE note with Pep'd Inc. ("Pep'd"), a US-based peptide company, expanding CDT's exposure to the growing US peptide market (the "Transaction"). Upon Pep’d closing an Equity Financing, this SAFE will automatically convert into a number of shares of Safe Preferred Stock, depending on the Pep’d Capitalization at that time and a Valuation Cap of $10,000,000. The Transaction extends CDT's strategy of identifying and backing high-potential and science-driven assets, and reflects the Company's growing interest in AI-enable
- SECAmendment: CDT Equity Inc. filed SEC Form 8-K: Financial Statements and Exhibits8-K/A - CDT Equity Inc. (0001896212) (Filer)
- SECAmendment: CDT Equity Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities8-K/A - CDT Equity Inc. (0001896212) (Filer)
- SECSEC Form 10-Q filed by CDT Equity Inc.10-Q - CDT Equity Inc. (0001896212) (Filer)
- SECSEC Form DEFA14A filed by CDT Equity Inc.DEFA14A - CDT Equity Inc. (0001896212) (Filer)
- SECSEC Form DEF 14A filed by CDT Equity Inc.DEF 14A - CDT Equity Inc. (0001896212) (Filer)
- SECCDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities8-K - CDT Equity Inc. (0001896212) (Filer)
- SECAmendment: CDT Equity Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K/A - CDT Equity Inc. (0001896212) (Filer)
- PRCDT Increases Stake in Sarborg following its Quantum Computing and Intellectual Property ExpansionNAPLES, Fla. and CAMBRIDGE, United Kingdom, Aug. 03, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company") today announced that it has entered into a strategic transaction to increase its equity stake in Sarborg Limited ("Sarborg"), an agentic AI signature intelligence business operating across multiple industrial sectors, to 22.7% through the issuance of pre-funded warrants to purchase up to 12,131,770 shares of the Company’s common stock, subject to shareholder approval at the Company’s annual meeting of stockholders on August 28, 2026 (the "Transaction"). The Transaction increases the Company’s shareholding in Sarborg, which was initially acquired in February 2
- SECSEC Form PRE 14A filed by CDT Equity Inc.PRE 14A - CDT Equity Inc. (0001896212) (Filer)
- SECCDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - CDT Equity Inc. (0001896212) (Filer)
- SECCDT Equity Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities8-K - CDT Equity Inc. (0001896212) (Filer)
- PRCDT Highlights Sarborg's Patent Filing Extending Quantum-Enabled PRISM Platform to SugarcaneNAPLES, Fla. and CAMBRIDGE, United Kingdom, July 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the filing of a new patent application covering a large set of field-deployable, two-component combination interventions for sugarcane cultivation, generated through Sarborg's quantum-enabled PRISM platform. According to Sarborg, the filing organizes its claimed combinations around six distinct application configurations, each defined by the growth stage of application, the delivery route, the dose and timing, and the agronomic target addressed. Within this framework, Sarborg has identified 606 fiel
- SECCDT Equity Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CDT Equity Inc. (0001896212) (Filer)
- PRCDT Equity Inc. Announces Reverse Stock SplitNAPLES, Fla. and CAMBRIDGE, United Kingdom, July 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), announces that its board of directors has approved a 1-for-10 reverse stock split of the Company’s common stock, to ensure continued compliance with the Nasdaq bid-price rule. The Company’s stockholders approved future reverse stock splits, their timing, and granted the board of directors authority to determine future exact split ratios. The reverse stock split will become effective on July 17, 2026, at 5:00 pm, Eastern Time (the "Effective Time"), and the Company’s common stock is expected to begin trading on a reverse stock split-adjusted basis on The Nasd
- SECSEC Form 10-Q filed by CDT Equity Inc.10-Q - CDT Equity Inc. (0001896212) (Filer)
- SECCDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - CDT Equity Inc. (0001896212) (Filer)
- SECCDT Equity Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - CDT Equity Inc. (0001896212) (Filer)
- PRCDT Highlights Sarborg's Application of Quantum Computing to Solid-Form DevelopmentNAPLES, Fla. and CAMBRIDGE, United Kingdom, June 26, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding the expansion of its Signature Intelligence platform into quantum-assisted coformer selection through SarborgQ, the Company's dedicated quantum computing division. According to Sarborg, the initiative combines the Company's proprietary datasets, agentic AI architecture and emerging quantum computing capabilities to support coformer selection across its owned intellectual property portfolio and future client engagements. Sarborg has curated a proprietary database of more than 850 coformers and is dev
- INSIDERLarge owner Taylor Mark Andrew sold $2,945,586 worth of shares (2,068,000 units at $1.42) (SEC Form 4)4 - CDT Equity Inc. (0001896212) (Issuer)
- PRCDT Notes Strategic Investment into Sarborg and Expansion into Quantum ComputingNAPLES, Fla. and CAMBRIDGE, United Kingdom, June 18, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today notes the announcement from Sarborg Limited regarding its recent fundraise from a New York-based private investment fund. According to Sarborg, the subscription was completed at a consideration per share of $125,000, implying a fully diluted valuation of approximately $638.3 million. The proceeds will be used to support the launch and development of SarborgQ, Sarborg's newly formed quantum computing division, alongside continued expansion of the Company's proprietary datasets, acceleration of intellectual property generation, support of asset developme
- SECCDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - CDT Equity Inc. (0001896212) (Filer)
- PRCDT Equity Announces Debt Update and New Loan FacilityNAPLES, Fla. and CAMBRIDGE, United Kingdom, June 16, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that it has re-structured its debt, agreeing to pay off all outstanding amounts due under its Loan Notes with Alliance Global Partners ("A.G.P.") and Ascent Partners, and entering into a new Loan Agreement with JJ Astor for up to $1,460,000. The A.G.P. Convertible Loan Note originally entered into in December 2024, had a principal amount of $5,737,500, which was repaid in full as of the beginning of June. In addition, the Company will repay $555,555.56 (exclusive of interest), pursuant to the Promissory Note with Ascent Partners entered int
- SECCDT Equity Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits8-K - CDT Equity Inc. (0001896212) (Filer)
- PRCDT Equity Inc. Announces Receipt of Nasdaq Deficiency LetterNAPLES, Fla. and CAMBRIDGE, United Kingdom, May 28, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (NASDAQ:CDT) ("CDT" or the "Company"), today announced that the Company received a written notice ("Notice") from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on May 21, 2026 indicating that the Company did not timely file its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2026 (the "Form 10-Q"), as required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5250(c)(1) (the "Periodic Filing Requirement"). The Notice does not have an immediate effect on the listing or trading of the Company's securiti
CDT FAQ
5 questionsWhere does CDT stock trade?
CDT Equity Inc. (CDT) is listed on NASDAQ.What sector and industry is CDT in?
CDT Equity Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did CDT Equity Inc. go public?
CDT Equity Inc. (CDT) completed its IPO in 2022.What companies are similar to CDT?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare CDT side-by-side with any of them on Quantisnow.How can I track CDT on Quantisnow?
Quantisnow aggregates CDT Equity Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CDT to receive live email and push alerts on every new disclosure.